Report Detail
Global Non-Invasive Cancer Diagnostics Market Research Report 2019
- RnM3200594 |
- 28 March, 2019 |
- Global |
- 98 Pages |
- QYResearch |
- Pharma & Healthcare
Global non invasive cancer diagnostics and technologies market is anticipated to show lucrative growth over the forecast period owing to factor such as rising demand for minimally invasive therapeutics and diagnosis for the treatment of cancer. Moreover, increasing prevalence of cancer because of rising aging population and unhealthy lifestyle is also important factor that is fueling the growth of this market. Commercialization of non invasive cancer diagnostics and technologies is expected to grow owing to completion of human genome project (HGP) which will help in identifying chemical base pairs which make up DNA, hence opening avenues for market players. Rising awareness amongst people about the advantages of early diagnosis and treatment of cancer has led to a hike in number of people undergoing diagnosis. Furthermore, growing research and development in cancer diagnosis and treatment is another factor that is boosting the growth. Advancements in cancer detection technologies like cancer biomarkers and fluorescence in situ hybridization (FISH) technique are also expected to contribute towards the growth of this market.
The global non invasive cancer diagnostics and technologies market is segmented into type and technology. Based on type this market is further sub segmented into breast cancer, blood cancer, lung cancer and solid tumors. Breast cancer held the largest share in 2014 owing to factor such as increasing incidence of breast cancer. Moreover, rising awareness amongst people about symptoms, diagnosis and therapies about breast cancer has contributed towards the dominance of this segment. Also, government and non-government organization’s (NGO) initiatives to create awareness about breast cancer early diagnosis and treatment are also helping to grow this market. Breast cancer segment is also expected to witness lucrative growth over the coming seven years as a consequence of advancements like lumpectomy and partial mastectomy. Based on technology the market is segmented into immunochemistry, molecular diagnosis and clinical chemistry. Molecular diagnostic market held the largest share in 2014 as a consequence of various advantages associated to it. These advantages include high precision of diagnosis such as high specificity, high sensitivity, and rapid turnaround time.
The global Non-Invasive Cancer Diagnostics market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Non-Invasive Cancer Diagnostics volume and value at global level, regional level and company level. From a global perspective, this report represents overall Non-Invasive Cancer Diagnostics market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.
The following manufacturers are covered:
Gen-Probe Inc
Digene Corporation
Quest Diagnostics Inc
Cancer, Genetics Inc
BIOVIEW Inc
AVIVA Biosciences Corporation
Laboratory Corporation of America Holdings (LabCorp)
A&G Pharmaceutical
Affymetrix Inc
Precision Therapeutics
Segment by Regions
North America
Europe
China
Japan
Segment by Type
CTCs
CTNAS
Exosomes
Segment by Application
Blood
Urine
Saliva
Table of Contents
Executive Summary
1 Non-Invasive Cancer Diagnostics Market Overview
- 1.1 Product Overview and Scope of Non-Invasive Cancer Diagnostics
- 1.2 Non-Invasive Cancer Diagnostics Segment by Type
- 1.2.1 Global Non-Invasive Cancer Diagnostics Production Growth Rate Comparison by Type (2014-2025)
- 1.2.2 CTCs
- 1.2.3 CTNAS
- 1.2.4 Exosomes
- 1.3 Non-Invasive Cancer Diagnostics Segment by Application
- 1.3.1 Non-Invasive Cancer Diagnostics Consumption Comparison by Application (2014-2025)
- 1.3.2 Blood
- 1.3.3 Urine
- 1.3.4 Saliva
- 1.4 Global Non-Invasive Cancer Diagnostics Market by Region
- 1.4.1 Global Non-Invasive Cancer Diagnostics Market Size Region
- 1.4.2 North America Status and Prospect (2014-2025)
- 1.4.3 Europe Status and Prospect (2014-2025)
- 1.4.4 China Status and Prospect (2014-2025)
- 1.4.5 Japan Status and Prospect (2014-2025)
- 1.5 Global Non-Invasive Cancer Diagnostics Market Size
- 1.5.1 Global Non-Invasive Cancer Diagnostics Revenue (2014-2025)
- 1.5.2 Global Non-Invasive Cancer Diagnostics Production (2014-2025)
2 Global Non-Invasive Cancer Diagnostics Market Competition by Manufacturers
- 2.1 Global Non-Invasive Cancer Diagnostics Production Market Share by Manufacturers (2014-2019)
- 2.2 Global Non-Invasive Cancer Diagnostics Revenue Share by Manufacturers (2014-2019)
- 2.3 Global Non-Invasive Cancer Diagnostics Average Price by Manufacturers (2014-2019)
- 2.4 Manufacturers Non-Invasive Cancer Diagnostics Production Sites, Area Served, Product Types
- 2.5 Non-Invasive Cancer Diagnostics Market Competitive Situation and Trends
- 2.5.1 Non-Invasive Cancer Diagnostics Market Concentration Rate
- 2.5.2 Non-Invasive Cancer Diagnostics Market Share of Top 3 and Top 5 Manufacturers
- 2.5.3 Mergers & Acquisitions, Expansion
3 Global Non-Invasive Cancer Diagnostics Production Market Share by Regions
- 3.1 Global Non-Invasive Cancer Diagnostics Production Market Share by Regions
- 3.2 Global Non-Invasive Cancer Diagnostics Revenue Market Share by Regions (2014-2019)
- 3.3 Global Non-Invasive Cancer Diagnostics Production, Revenue, Price and Gross Margin (2014-2019)
- 3.4 North America Non-Invasive Cancer Diagnostics Production
- 3.4.1 North America Non-Invasive Cancer Diagnostics Production Growth Rate (2014-2019)
- 3.4.2 North America Non-Invasive Cancer Diagnostics Production, Revenue, Price and Gross Margin (2014-2019)
- 3.5 Europe Non-Invasive Cancer Diagnostics Production
- 3.5.1 Europe Non-Invasive Cancer Diagnostics Production Growth Rate (2014-2019)
- 3.5.2 Europe Non-Invasive Cancer Diagnostics Production, Revenue, Price and Gross Margin (2014-2019)
- 3.6 China Non-Invasive Cancer Diagnostics Production (2014-2019)
- 3.6.1 China Non-Invasive Cancer Diagnostics Production Growth Rate (2014-2019)
- 3.6.2 China Non-Invasive Cancer Diagnostics Production, Revenue, Price and Gross Margin (2014-2019)
- 3.7 Japan Non-Invasive Cancer Diagnostics Production (2014-2019)
- 3.7.1 Japan Non-Invasive Cancer Diagnostics Production Growth Rate (2014-2019)
- 3.7.2 Japan Non-Invasive Cancer Diagnostics Production, Revenue, Price and Gross Margin (2014-2019)
4 Global Non-Invasive Cancer Diagnostics Consumption by Regions
- 4.1 Global Non-Invasive Cancer Diagnostics Consumption by Regions
- 4.2 North America Non-Invasive Cancer Diagnostics Consumption (2014-2019)
- 4.3 Europe Non-Invasive Cancer Diagnostics Consumption (2014-2019)
- 4.4 China Non-Invasive Cancer Diagnostics Consumption (2014-2019)
- 4.5 Japan Non-Invasive Cancer Diagnostics Consumption (2014-2019)
5 Global Non-Invasive Cancer Diagnostics Production, Revenue, Price Trend by Type
- 5.1 Global Non-Invasive Cancer Diagnostics Production Market Share by Type (2014-2019)
- 5.2 Global Non-Invasive Cancer Diagnostics Revenue Market Share by Type (2014-2019)
- 5.3 Global Non-Invasive Cancer Diagnostics Price by Type (2014-2019)
- 5.4 Global Non-Invasive Cancer Diagnostics Production Growth by Type (2014-2019)
6 Global Non-Invasive Cancer Diagnostics Market Analysis by Applications
- 6.1 Global Non-Invasive Cancer Diagnostics Consumption Market Share by Application (2014-2019)
- 6.2 Global Non-Invasive Cancer Diagnostics Consumption Growth Rate by Application (2014-2019)
7 Company Profiles and Key Figures in Non-Invasive Cancer Diagnostics Business
- 7.1 Gen-Probe Inc
- 7.1.1 Gen-Probe Inc Non-Invasive Cancer Diagnostics Production Sites and Area Served
- 7.1.2 Non-Invasive Cancer Diagnostics Product Introduction, Application and Specification
- 7.1.3 Gen-Probe Inc Non-Invasive Cancer Diagnostics Production, Revenue, Price and Gross Margin (2014-2019)
- 7.1.4 Main Business and Markets Served
- 7.2 Digene Corporation
- 7.2.1 Digene Corporation Non-Invasive Cancer Diagnostics Production Sites and Area Served
- 7.2.2 Non-Invasive Cancer Diagnostics Product Introduction, Application and Specification
- 7.2.3 Digene Corporation Non-Invasive Cancer Diagnostics Production, Revenue, Price and Gross Margin (2014-2019)
- 7.2.4 Main Business and Markets Served
- 7.3 Quest Diagnostics Inc
- 7.3.1 Quest Diagnostics Inc Non-Invasive Cancer Diagnostics Production Sites and Area Served
- 7.3.2 Non-Invasive Cancer Diagnostics Product Introduction, Application and Specification
- 7.3.3 Quest Diagnostics Inc Non-Invasive Cancer Diagnostics Production, Revenue, Price and Gross Margin (2014-2019)
- 7.3.4 Main Business and Markets Served
- 7.4 Cancer, Genetics Inc
- 7.4.1 Cancer, Genetics Inc Non-Invasive Cancer Diagnostics Production Sites and Area Served
- 7.4.2 Non-Invasive Cancer Diagnostics Product Introduction, Application and Specification
- 7.4.3 Cancer, Genetics Inc Non-Invasive Cancer Diagnostics Production, Revenue, Price and Gross Margin (2014-2019)
- 7.4.4 Main Business and Markets Served
- 7.5 BIOVIEW Inc
- 7.5.1 BIOVIEW Inc Non-Invasive Cancer Diagnostics Production Sites and Area Served
- 7.5.2 Non-Invasive Cancer Diagnostics Product Introduction, Application and Specification
- 7.5.3 BIOVIEW Inc Non-Invasive Cancer Diagnostics Production, Revenue, Price and Gross Margin (2014-2019)
- 7.5.4 Main Business and Markets Served
- 7.6 AVIVA Biosciences Corporation
- 7.6.1 AVIVA Biosciences Corporation Non-Invasive Cancer Diagnostics Production Sites and Area Served
- 7.6.2 Non-Invasive Cancer Diagnostics Product Introduction, Application and Specification
- 7.6.3 AVIVA Biosciences Corporation Non-Invasive Cancer Diagnostics Production, Revenue, Price and Gross Margin (2014-2019)
- 7.6.4 Main Business and Markets Served
- 7.7 Laboratory Corporation of America Holdings (LabCorp)
- 7.7.1 Laboratory Corporation of America Holdings (LabCorp) Non-Invasive Cancer Diagnostics Production Sites and Area Served
- 7.7.2 Non-Invasive Cancer Diagnostics Product Introduction, Application and Specification
- 7.7.3 Laboratory Corporation of America Holdings (LabCorp) Non-Invasive Cancer Diagnostics Production, Revenue, Price and Gross Margin (2014-2019)
- 7.7.4 Main Business and Markets Served
- 7.8 A&G Pharmaceutical
- 7.8.1 A&G Pharmaceutical Non-Invasive Cancer Diagnostics Production Sites and Area Served
- 7.8.2 Non-Invasive Cancer Diagnostics Product Introduction, Application and Specification
- 7.8.3 A&G Pharmaceutical Non-Invasive Cancer Diagnostics Production, Revenue, Price and Gross Margin (2014-2019)
- 7.8.4 Main Business and Markets Served
- 7.9 Affymetrix Inc
- 7.9.1 Affymetrix Inc Non-Invasive Cancer Diagnostics Production Sites and Area Served
- 7.9.2 Non-Invasive Cancer Diagnostics Product Introduction, Application and Specification
- 7.9.3 Affymetrix Inc Non-Invasive Cancer Diagnostics Production, Revenue, Price and Gross Margin (2014-2019)
- 7.9.4 Main Business and Markets Served
- 7.10 Precision Therapeutics
- 7.10.1 Precision Therapeutics Non-Invasive Cancer Diagnostics Production Sites and Area Served
- 7.10.2 Non-Invasive Cancer Diagnostics Product Introduction, Application and Specification
- 7.10.3 Precision Therapeutics Non-Invasive Cancer Diagnostics Production, Revenue, Price and Gross Margin (2014-2019)
- 7.10.4 Main Business and Markets Served
8 Non-Invasive Cancer Diagnostics Manufacturing Cost Analysis
- 8.1 Non-Invasive Cancer Diagnostics Key Raw Materials Analysis
- 8.1.1 Key Raw Materials
- 8.1.2 Price Trend of Key Raw Materials
- 8.1.3 Key Suppliers of Raw Materials
- 8.2 Proportion of Manufacturing Cost Structure
- 8.3 Manufacturing Process Analysis of Non-Invasive Cancer Diagnostics
- 8.4 Non-Invasive Cancer Diagnostics Industrial Chain Analysis
9 Marketing Channel, Distributors and Customers
- 9.1 Marketing Channel
- 9.1.1 Direct Marketing
- 9.1.2 Indirect Marketing
- 9.2 Non-Invasive Cancer Diagnostics Distributors List
- 9.3 Non-Invasive Cancer Diagnostics Customers
10 Market Dynamics
- 10.1 Market Trends
- 10.2 Opportunities
- 10.3 Market Drivers
- 10.4 Challenges
- 10.5 Influence Factors
11 Global Non-Invasive Cancer Diagnostics Market Forecast
- 11.1 Global Non-Invasive Cancer Diagnostics Production, Revenue Forecast
- 11.1.1 Global Non-Invasive Cancer Diagnostics Production Growth Rate Forecast (2019-2025)
- 11.1.2 Global Non-Invasive Cancer Diagnostics Revenue and Growth Rate Forecast (2019-2025)
- 11.1.3 Global Non-Invasive Cancer Diagnostics Price and Trend Forecast (2019-2025)
- 11.2 Global Non-Invasive Cancer Diagnostics Production Forecast by Regions (2019-2025)
- 11.2.1 North America Non-Invasive Cancer Diagnostics Production, Revenue Forecast (2019-2025)
- 11.2.2 Europe Non-Invasive Cancer Diagnostics Production, Revenue Forecast (2019-2025)
- 11.2.3 China Non-Invasive Cancer Diagnostics Production, Revenue Forecast (2019-2025)
- 11.2.4 Japan Non-Invasive Cancer Diagnostics Production, Revenue Forecast (2019-2025)
- 11.3 Global Non-Invasive Cancer Diagnostics Consumption Forecast by Regions (2019-2025)
- 11.3.1 North America Non-Invasive Cancer Diagnostics Consumption Forecast (2019-2025)
- 11.3.2 Europe Non-Invasive Cancer Diagnostics Consumption Forecast (2019-2025)
- 11.3.3 China Non-Invasive Cancer Diagnostics Consumption Forecast (2019-2025)
- 11.3.4 Japan Non-Invasive Cancer Diagnostics Consumption Forecast (2019-2025)
- 11.4 Global Non-Invasive Cancer Diagnostics Production, Revenue and Price Forecast by Type (2019-2025)
- 11.5 Global Non-Invasive Cancer Diagnostics Consumption Forecast by Application (2019-2025)
12 Research Findings and Conclusion
13 Methodology and Data Source
- 13.1 Methodology/Research Approach
- 13.1.1 Research Programs/Design
- 13.1.2 Market Size Estimation
- 13.1.3 Market Breakdown and Data Triangulation
- 13.2 Data Source
- 13.2.1 Secondary Sources
- 13.2.2 Primary Sources
- 13.3 Author List
Summary:
Get latest Market Research Reports on Non-Invasive Cancer Diagnostics . Industry analysis & Market Report on Non-Invasive Cancer Diagnostics is a syndicated market report, published as Global Non-Invasive Cancer Diagnostics Market Research Report 2019. It is complete Research Study and Industry Analysis of Non-Invasive Cancer Diagnostics market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
